Changsha Dian Medical Laboratory Co., Ltd.

Zhejiang Dian Diagnostics Technology Co., Ltd. was founded in 2001 and is a third-party medical diagnostic service institution with diagnostic service outsourcing as its core business. It was listed in July 2011 (stock code: 300244), achieving a 'zero breakthrough' for Chinese independent medical laboratories in going public. It currently has more than 6,000 employees, and in 2016, its annual revenue exceeded 2.8 billion yuan, maintaining a compound growth rate of over 40% for five consecutive years. Changsha Dian Medical Laboratory (hereinafter referred to as Changsha Dian) was invested and established by the Dian Diagnostics Group. Its business scope is based in Hunan and radiates to surrounding provinces. Relying on the Dian Group's standardized operating model and experience, it introduces advanced testing technology and service concepts into the Hunan medical market. Changsha Dian conforms to the direction of China's medical and health system reform and expands specialized and market-oriented third-party medical testing services. Changsha Dian is located at Lugu Yuyuan, No. 27 Wenxuan Road, Changsha High-tech Zone, with a building area of 2,463 square meters. Currently, its large blood testing instruments include: Roche fully automated biochemical analyzer COBAS6000 (C501+E601) module, Siemens fully automated immunoassay analyzer XP, Roche Z480 fluorescence quantitative gene amplifier, Sysmex five-part blood counter, Ruiyang Class II biological safety cabinet, Antu microplate reader, Huakerui 3096 plate washer, Beijing Puxi multi-channel atomic absorption spectrophotometer, blood lead and cadmium analyzer, Thermo carbon dioxide incubator, etc. Pathological diagnosis equipment includes: OLYMPUS BX43 trinocular/Nikon CI-S trinocular microscope, LEICA RM2235 microtome, Zhongwei BMJ-B embedding machine, Jiangsu Runyu slide cabinet and other large instruments. Changsha Dian has an excellent talent team and senior management team composed of testing experts, clinical professors, and various medical professionals. Adhering to the business philosophy of 'integrity, diligence, pragmatism, and innovation' and the service purpose of 'striving for perfection and caring for health with heart', it provides customers with * product technology and value-added service support. Dian Diagnostics has established 35 chain laboratories (including those under construction) across the country, and has successively passed ISO15189 and CAP international quality certification and accreditation systems. It can provide more than 2,000 medical testing items and offer integrated medical diagnostic service solutions with service outsourcing as the core to more than 12,000 medical institutions nationwide, providing precise diagnostic services to hundreds of millions of people. Relying on the national chain medical laboratory platform, Dian is committed to technological innovation and business model innovation. Its business involves forensic appraisal, diagnostic product and service sales, diagnostic technology research and development and production, forensic appraisal, health management, CRO, biobank and other fields. It continuously improves the integrated professional service system of 'service + product', forming an integrated marketing competitive advantage, determining the expansion strategy of national chain and large-scale replication. Through effective vertical and horizontal resource integration, it accelerates the pace of national layout and launches the integrated development strategy of expanding the public testing platform into multiple service fields and integrating upstream and downstream industry chains. The Dian Testing Center includes a mass spectrometry analysis platform, high-throughput gene sequencing platform, personalized diagnosis platform, hematological disease diagnosis platform, autoimmune disease diagnosis platform, allergic disease diagnosis platform, infant disease diagnosis platform, gynecological disease diagnosis platform, etc., providing hospitals with high-end and advanced testing and diagnosis items and doctors with comprehensive diagnostic opinions. The expert team of the Pathology Center is mature and stable, combining senior, middle-aged, and young experts. With a high-quality laboratory environment and hardware implementation, a well-established logistics transportation mechanism, a good operational service mechanism, and an excellent 'digital slide' platform, it has strived to build a three-level pathological diagnosis and consultation platform consisting of a 'basic pathological diagnosis center - advanced pathological diagnosis center - advanced pathological consultant team', improving the establishment and discipline construction of various pathological subspecialties, and strengthening pathological diagnosis literacy and diagnosis quality control. With the deepening of the new healthcare reform, the intensification of social aging, and the rise of personalized diagnosis and treatment, Dian will leverage the momentum of the booming big health service industry, give full play to its advantages such as a unique business model, innovative technology research and development, and a complete management system, take 'letting Chinese people share health equally' as its mission, build a big health industry ecosystem, achieve win-win results for medical institutions, the government, and the public, and 'become a respected * in the diagnostic industry'. We eagerly look forward to you, as future elites in the medical industry, joining us. While realizing your self-worth, you will help advance China's new healthcare reform, contribute to the cause of social health, and develop rapidly together with Dian.